Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Symptoms, Doctors, Treatments, Advances & More

Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome) Overview

Save information for later
Sign Up

Learn About Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)

What is the definition of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)?
Eosinophilic granulomatosis with polyangiitis (Churg Strauss syndrome) is a condition characterized by asthma, high levels of eosinophils (a type of white blood cell that helps fight infection), and inflammation of small to medium sized blood vessels (vasculitis). The inflamed vessels can affect various organ systems including the lungs, gastrointestinal tract, skin, heart and nervous system. The exact cause of Eosinophilic granulomatosis with polyangiitis is unknown, but it is thought to be an autoimmune disorder.
Who are the top Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome) Local Doctors?
Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Pulmonary Medicine
Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Pulmonary Medicine

National Jewish Health

1400 Jackson Street, Pulmonary Medicine 1, Suite A542, 
Denver, CO 
Experience:
33+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

National Jewish Health. Dr. Wechsler is rated as an Elite provider by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Asthma, Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Hypereosinophilic Syndrome, and Eosinophilic Asthma. Dr. Wechsler is board certified in American Board Of Internal Medicine. Dr. Wechsler is currently accepting new patients.

Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Rheumatology
Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Rheumatology

Cleveland Clinic Main Campus

2049 East 100th Street, 
Cleveland, OH 
Experience:
43+ years
Languages Spoken:
English
Offers Telehealth

Carol Langford is a Rheumatologist practicing medicine in Cleveland, Ohio. She has been practicing medicine for over 43 years. Dr. Langford is rated as an Elite provider by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Granulomatosis with Polyangiitis, Vasculitis, Takayasu Arteritis, Microscopic Polyangiitis, and Tissue Biopsy. Dr. Langford is board certified in American Board Of Internal Medicine, 1994.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Intensive Care Medicine
Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Intensive Care Medicine

University Of California San Diego Jacobs Medical Center

9300 Campus Point Dr, 
La Jolla, CA 
Languages Spoken:
English
Offers Telehealth

Praveen Akuthota is an Intensive Care Medicine provider practicing medicine in La Jolla, California. Dr. Akuthota is rated as an Elite provider by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Hypereosinophilic Syndrome, Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Asthma, Eosinophilic Asthma, and Gastrostomy.

What are the latest Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome) Clinical Trials?
Longitudinal Protocol for Eosinophilic Granulomatosis With Polyangiitis

Summary: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
VCRC Genetic Repository One-Time DNA Protocol

Summary: The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researc...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center